Skip to content
The Nexus
DossierENTITY

resectable esophageal cancer

Coverage of resectable esophageal cancer in the Nexus archive.

Earliest in view: Jun 23 · 21:31 UTCMost recent: Jun 23 · 21:31 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 23 · 21:31 UTCMEDPAGE TODAY
    Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer

    The article discusses the emergence and ongoing promise of immunotherapy for resectable esophageal cancer, a disease historically associated with poor prognosis. It highlights that immunotherapy has provided hope to patients and clinicians, with recent developments suggesting sustained or improved outcomes.